These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22409544)

  • 1. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena.
    Ramanathan R; Korfmacher W
    Bioanalysis; 2012 Mar; 4(5):467-9. PubMed ID: 22409544
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conference report: European Bioanalysis Forum.
    Abbott RW; Brudny-Kloeppel M
    Bioanalysis; 2009 May; 1(2):273-6. PubMed ID: 21083164
    [No Abstract]   [Full Text] [Related]  

  • 4. Using high-resolution quadrupole TOF technology in DMPK analyses.
    Campbell JL; Le Blanc JC
    Bioanalysis; 2012 Mar; 4(5):487-500. PubMed ID: 22409548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures.
    Korfmacher W
    Bioanalysis; 2011 Jun; 3(11):1169-71. PubMed ID: 21649491
    [No Abstract]   [Full Text] [Related]  

  • 6. Future directions of imaging MS in pharmaceutical R&D.
    Goodwin RJ; Webborn PJ
    Bioanalysis; 2015; 7(20):2667-73. PubMed ID: 26510897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery.
    Servais AC; Crommen J; Fillet M
    Electrophoresis; 2006 Jul; 27(13):2616-29. PubMed ID: 16817163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontarget analysis of polar contaminants in freshwater sediments influenced by pharmaceutical industry using ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Terzic S; Ahel M
    Environ Pollut; 2011 Feb; 159(2):557-66. PubMed ID: 21056522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry for structural characterization of therapeutic antibodies.
    Zhang Z; Pan H; Chen X
    Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
    Chen J; Korfmacher WA; Hsieh Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays.
    Zhang J; Maloney J; Drexler DM; Cai X; Stewart J; Mayer C; Herbst J; Weller H; Shou WZ
    Bioanalysis; 2012 Mar; 4(5):581-93. PubMed ID: 22409555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.